SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001698530-18-000081
Filing Date
2018-10-10
Accepted
2018-10-10 17:24:24
Documents
14
Period of Report
2018-10-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K exicure8-k101018.htm 8-K 24010
2 EXHIBIT 99.1 exhibit991-8k101018.htm EX-99.1 287901
3 a201809developmentpipelinev0.jpg GRAPHIC 194791
4 ast008breastcancer.jpg GRAPHIC 141436
5 ast008coloncancer.jpg GRAPHIC 76699
6 ast008lymphoma.jpg GRAPHIC 198798
7 ast008melanoma.jpg GRAPHIC 82069
8 ibddata.jpg GRAPHIC 228362
9 ophthalmologyrabbiteyesdata.jpg GRAPHIC 52904
10 respiratoryactivitydata.jpg GRAPHIC 61655
11 smainvivogreyscale.jpg GRAPHIC 107198
12 snatlrgraphica06.jpg GRAPHIC 169380
13 twosnasa04.jpg GRAPHIC 299852
14 xcur17preclinicalresults.jpg GRAPHIC 612610
  Complete submission text file 0001698530-18-000081.txt   3353597
Mailing Address 8045 LAMON AVE, SUITE 410 SKOKIE IL 60077
Business Address 8045 LAMON AVE, SUITE 410 SKOKIE IL 60077 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

IRS No.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55764 | Film No.: 181116731
SIC: 2834 Pharmaceutical Preparations